About Fabian Seelbach
Form D filings for GLO Pharma in 2023 list Fabian Seelbach as director.
Fabian Seelbach first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Fabian Seelbach in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Fabian Seelbach works with at each company, as listed on that company's latest Form D.
GLO Pharma, Inc. · Form D/A, Sep 11, 2023
DQ
Dayna Quanbeck
Director
NQ
Nicole Quinn
Director
MB
Marla Beck
Director
MC
Maureen Case
Director
DW
Douglas Wall
Director
LO
Lauren Otsuki
Executive officer and director
VG
Vimla Black-Gupta
President and Chief Executive Officer, director